Cited by 67

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity

Yang, Dong‐Hua, Smith, Elizabeth R., Cohen, Cynthia, Wu, Hong, Patriotis, Christos, Godwin, Andrew K., Hamilton, Thomas C., Xu, Xiang‐Xi·2002·Cancer

Abstract

BACKGROUND: Disabled‐2 (Dab2), a candidate tumor suppressor of ovarian carcinoma, frequently (around 80%) loses its expression in ovarian tumors. Expression of exogenous Dab2 in tumor cell lines negatively regulates growth and suppresses the downstream signal of the Ras/mitogen activated protein kinase mitogenic pathway. The inactivation of Dab2 is believed to be an early event in ovarian tumorigenicity. METHODS: The authors analyzed the correlation among expression of Dab2, presence of basement membrane (collagen IV and laminin), morphologic alteration of the surface epithelial cells, and expression of the mitotic index marker Mib‐1 in 50 archived ovarian tumors by an immunohistochemical approach. The stainings of Dab2, Mib‐1, collagen IV, and laminin in premalignant lesions bordering both normal and neoplastic ovarian surface epithelium from adjacent slides were analyzed in 50 ovarian tumors. RESULTS: In these 50 ovarian tumors, the percentage of Mib‐1 positive tumor cells distributed in a wide range, from 1% to 75%, and there has no strong correlation with the expression of Dab2. However, in the premalignant regions bordering tumor and normal ovarian surface epithelium, the loss of Dab2 expression closely correlated with the dysplastic morphologic transition and Mib‐1 expression of the ovarian surface epithelial cells. In 20 foci in 12 out of the 50 tumors, a transition from normal to neoplastic morphology within a contiguous epithelium was observed, and in all cases the morphologic change correlated with the loss of Dab2 staining. In addition, the collagen and laminin staining of the basement membrane were absent or weakened in pre‐malignant epithelium prior to loss of Dab2 expression in all these 20 cases. Nevertheless, collagen IV and laminin were detectable in established adenomas on the same tumor slides. CONCLUSIONS: The loss of Dab2 is closely associated with the transition of ovarian surface epithelial cells to premalignant states and is likely involved in the initiation of ovarian tumorigenicity. Transient loss of collagen IV and laminin in the basement membrane of the premalignant epithelium and subsequent inactivation of Dab2 are common early events associated with tumorigenicity of the ovarian surface epithelium. Cancer 2002;94:2380–92. © 2002 American Cancer Society. DOI 10.1002/cncr.10497

Overview

Integrity signals

Registry

Crossref · 10.1002/cncr.10497

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dab2 tumor suppressor function is attributed to epithelial organization.

    “epithelial organization (Sheng et al., 2000b; Yang et al., 2002b, 2007)”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Yang et al., 2002b

  • Loss of Dab2 expression occurs in an epithelial layer and correlates closely with morphological transformation from a benign monolayer to malignant multiple layered ovarian cancer.

    “A suggestive observation is that the loss of Dab2 expression occurs in an epithelial layer, and correlates closely with morphological transformation from a benign monolayer to malignant multiple layered ovarian cancer (Yang et al., 2002b).”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Yang et al., 2002b

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. 10.1002/cncr.2820710207 · DOI
  2. 10.1002/cncr.2820710426 · DOI
  3. 10.1007/978-1-4615-5447-9_2 · DOI
  4. 10.1016/0028-2243(85)90059-0 · DOI
  5. 10.1095/biolreprod44.4.717 · DOI
  6. 10.1016/S0140-6736(71)92335-X · DOI
  7. 10.1046/j.1365-2265.1998.00577.x · DOI
  8. 10.1016/S0140-6736(99)02250-3 · DOI
  9. 10.1093/jnci/84.8.592 · DOI
  10. Testa JR, 1994, Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity, Cancer Res., 54, 2778
  11. 10.1002/jcb.240590928 · DOI
  12. 10.1046/j.1365-2559.2001.01042.x · DOI
  13. 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L · DOI
  14. 10.1093/jnci/88.24.1810 · DOI
  15. 10.1097/00004347-199301000-00008 · DOI
  16. Aoki Y, 2000, Early form of ovarian cancer originating in inclusion cysts. A case report, J Reprod Med., 45, 159
  17. 10.1093/jnci/88.24.1790 · DOI
  18. 10.1074/jbc.270.23.14184 · DOI · Paper page
  19. Wong KK, 1993, Identification of differentially expressed RNA in human ovarian carcinoma cells by arbitrarily primed PCR fingerprinting of total RNA, Intl J Oncol., 3, 13
  20. 10.1038/sj.onc.1201769 · DOI · Paper page
  21. 10.1038/sj.onc.1202649 · DOI · Paper page
  22. 10.1038/sj.onc.1203853 · DOI
  23. 10.1006/geno.1996.0185 · DOI
  24. 10.1006/geno.2000.6383 · DOI
  25. 10.1038/sj.onc.1201678 · DOI
  26. 10.1074/jbc.M101820200 · DOI
  27. Kirkegaard LJ, 1998, Image cytometric measurement of nuclear proliferation markers (MIB‐1, PCNA) in astrocytomas. Prognostic significance, Am J Clin Pathol., 109, 69, 10.1093/ajcp/109.1.69 · DOI
  28. 10.1007/BF02632043 · DOI
  29. 10.1210/er.22.2.255 · DOI
  30. 10.1006/gyno.1998.5094 · DOI
  31. 10.1002/(SICI)1097-0320(19960915)26:3<198::AID-CYTO3>3.0.CO;2-B · DOI
  32. 10.1093/ajcp/96.4.444 · DOI
  33. 10.1007/BF01192204 · DOI
  34. 10.1006/gyno.1995.1026 · DOI
  35. Marx D, 1997, Mib‐1 evaluated proliferative activity in ovarian cancer with respect to prognostic significance, Anticancer Res., 17, 775
  36. 10.1016/0092-8674(89)90407-8 · DOI · Paper page
  37. 10.1101/gad.7.3.441 · DOI · Paper page
  38. 10.1038/39607 · DOI · Paper page
  39. 10.1016/S0896-6273(00)80936-8 · DOI
  40. 10.1016/S0092-8674(00)80782-5 · DOI · Paper page
  41. 10.1074/jbc.M106158200 · DOI · Paper page
  42. 10.1074/jbc.M105009200 · DOI
  43. Kuwashima Y, 1995, Basement membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type IV collagen and laminin, Eur J Gynaecol Oncol., 16, 181
  44. 10.1097/00000478-199205000-00009 · DOI
  45. Crawford HC, 1994, Tumor and stromal expression of matrix metalloproteinase and their role in tumor progression, Invasion Metastasis., 14, 234
  46. 10.1002/ijc.2910580110 · DOI
  47. 10.1002/ijc.2910560415 · DOI
  48. 10.1006/gyno.2000.5806 · DOI
  49. 10.1002/ijc.2910550119 · DOI
  50. Mok SC, 1996, SPARC, an extracellular matrix protein with tumor‐suppressing activity in human ovarian epithelial cells, Oncogene., 12, 1895
  51. 10.1038/sj.onc.1201385 · DOI
  52. Skubitz APN, 1996, Expression of _6 and _4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin, Am J Pathol., 148, 1445
  53. 10.1097/00004347-199901000-00007 · DOI
  54. 10.1126/science.7531366 · DOI
  55. 10.1242/dev.117.4.1183 · DOI
  56. 10.1016/0092-8674(75)90188-9 · DOI
  57. 10.1016/0039-128X(89)90040-8 · DOI

Cited by

Sorted by citations

Metadata

Authors
Yang, D., Smith, E. R., Cohen, C., Wu, H., Patriotis, C., Godwin, A. K., Hamilton, T. C., & Xu, X.
Venue
Cancer
Publisher
Wiley
Published
2002-04-25
Volume
94
Issue
9
Pages
2380-2392
ISSN
  • 0008-543X
  • 1097-0142
Cited by
67
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review